ArticleThe Pan African medical journal2026
Association of oxidative stress, inflammation, and ADIPOQ gene expression in young adults at risk of non-alcoholic fatty liver disease and cardiovascular disease.
Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: non-alcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVD) are increasingly seen in young adults due to obesity, sedentary lifestyle, and poor diet. Oxidative stress and chronic inflammation are key contributors to their development, promoting liver damage, endothelial dysfunction, and atherosclerosis. Adiponectin, encoded by the ADIPOQ gene, has protective metabolic effects, and its reduction, often influenced by genetic factors, is linked to increased disease risk. This study evaluates the relationship between oxidative stress (MDA), inflammation (IL-6), and ADIPOQ gene expression in young adults to identify early biomarkers. Methods: this case-control study (2022 December-2024 December) included 300 participants aged 18-45 years with clinically established non-alcoholic fatty liver and/or cardiovascular risk disease, who were categorized as the case group. The remaining 150 healthy individuals served as the control group. MDA and IL-6 levels were measured using ELISA, while ADIPOQ expression was analyzed via reverse transcription polymerase chain reaction (RT-PCR). Data were analyzed using t-tests, receiver operating characteristic (ROC) analysis, and quantile regression in Stata 17.0, with significance set at p<0.05. Results: cases showed elevated MDA and IL-6 levels and reduced ADIPOQ expression compared to controls. ROC analysis identified MDA as the strongest biomarker (AUC = 0.9605). IL-6 showed diagnostic potential but lost significance after adjustment for sociodemographic variables. MDA and IL-6 levels negatively correlated with ADIPOQ expression. Conclusion: oxidative stress and inflammation are associated with reduced ADIPOQ expression in young adults at risk of NAFLD and CVD. While ADIPOQ alone may have limited predictive power, early identification of oxidative and inflammatory markers could aid in timely intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.